Literature DB >> 22293493

Critical role of mTOR in calcineurin inhibitor-induced renal cancer progression.

Aninda Basu, Pallavi Banerjee, Soumitro Pal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22293493      PMCID： PMC3318099          DOI： 10.4161/cc.11.4.19276

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  11 in total

1.  Feedback inhibition of calcineurin and Ras by a dual inhibitory protein Carabin.

Authors:  Fan Pan; Luo Sun; David B Kardian; Katharine A Whartenby; Drew M Pardoll; Jun O Liu
Journal:  Nature       Date:  2007-01-17       Impact factor: 49.962

2.  Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.

Authors:  Emilie Vander Haar; Seong-Il Lee; Sricharan Bandhakavi; Timothy J Griffin; Do-Hyung Kim
Journal:  Nat Cell Biol       Date:  2007-02-04       Impact factor: 28.824

3.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor.

Authors:  Markus Guba; Philipp von Breitenbuch; Markus Steinbauer; Gudrun Koehl; Stefanie Flegel; Matthias Hornung; Christiane J Bruns; Carl Zuelke; Stefan Farkas; Matthias Anthuber; Karl-Walter Jauch; Edward K Geissler
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

4.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.

Authors:  J Liu; J D Farmer; W S Lane; J Friedman; I Weissman; S L Schreiber
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

5.  Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development.

Authors:  Aninda Basu; Dipak Datta; David Zurakowski; Soumitro Pal
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

6.  Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells.

Authors:  Dipak Datta; Alan G Contreras; Aninda Basu; Olivier Dormond; Evelyn Flynn; David M Briscoe; Soumitro Pal
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

7.  Cancer after kidney transplantation in the United States.

Authors:  Bertram L Kasiske; Jon J Snyder; David T Gilbertson; Changchun Wang
Journal:  Am J Transplant       Date:  2004-06       Impact factor: 8.086

Review 8.  Prevention of cancer by inhibiting aging.

Authors:  Mikhail V Blagosklonny
Journal:  Cancer Biol Ther       Date:  2008-10-21       Impact factor: 4.742

9.  Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer.

Authors:  Aninda Basu; Alan G Contreras; Dipak Datta; Evelyn Flynn; Liling Zeng; Herbert T Cohen; David M Briscoe; Soumitro Pal
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

10.  Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40.

Authors:  Aninda Basu; Pallavi Banerjee; Alan G Contreras; Evelyn Flynn; Soumitro Pal
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240
View more
  1 in total

1.  Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway.

Authors:  Miriam B F Werneck; Eugênio Hottz; Patricia T Bozza; João P B Viola
Journal:  Cell Cycle       Date:  2012-09-19       Impact factor: 4.534
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.